atopic dermatitis

target reach ladder climb meet win beat competition
Biotech

Amgen reports first phase 3 win for $400M eczema drug

While the trial met its primary endpoints, Amgen still needs to make the case that there is a role for rocatinlimab in a market served by Dupixent.
Nick Paul Taylor Sep 25, 2024 5:50am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Connect reduces China workforce, mulls strategy for asthma drug

Sep 6, 2024 4:37am
photo of a sign labeled closed on a business window

Aslan’s dream of challenging Dupixent dies as biotech winds down

Jul 17, 2024 8:36am
ice cream scoop cone

J&J scoops up another atopic dermatitis drug for $1.25B

May 28, 2024 8:30am
Deal terminate tear up end deal scrap

Connect uncouples from Pfizer by scrapping eczema pact

Apr 17, 2024 6:38am
eczema atopic dermatitis Black African American patient skin of color

Lilly's lebrikizumab clears eczema in people with skin of color

Mar 11, 2024 9:24am